Earnings Call · Q4 FY2025·2026-02-26

Q4 25EPS -46.67%·Rev n/aQ3 25EPS +7.69%·Rev n/aQ2 25EPS +4.23%·Rev n/aQ1 25EPS +3.33%·Rev n/a⚠ consensus missing

Pacira BioSciences, Inc. PCRX

Susan Mesco — Investor Relations

Frank Lee — Chief Executive Officer

Brendan P. Teehan — Chief Commercial Officer

Shawn M. Cross — Chief Financial Officer

−3.0%1d on move date−2.5% vs SPY3d−2.2%5d+1.2%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PCRX calls or request research access.

More PCRX calls Browse calls Request research access